A randomized trial evaluating the efficacy and safety of ENA 73 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer disease - Corey-Bloom, J; Anand, R; Veach, J (Int J Geriatr Psychopharmacol, 1998)